Announcements Trials

Browse Landscape

Phase

Status

Recruiting 8 Completed 2 Terminated 1 Suspended 1 Not yet recruiting 1 Available 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1 Glioma 1 Glioblastoma 1

Interventions

Specimen Handling 76 Cisplatin 64 Drug Therapy 63 Carboplatin 63 Bevacizumab 63 Magnetic Resonance Spectroscopy 59 Radiotherapy 57 Gemcitabine 54 Cyclophosphamide 54 pembrolizumab 52 Oxaliplatin 49 Capecitabine 49 toripalimab 44 Paclitaxel 40 tislelizumab 39 Standard of Care 39 fludarabine 36 Injections 34 Fluorouracil 34 Biopsy 34 venetoclax 33 Blood Specimen Collection 31 Immune Checkpoint Inhibitors 30 anlotinib 28 Nivolumab 28 Surgical Procedures, Operative 27 Irinotecan 27 Docetaxel 27 Leucovorin 26 Dexamethasone 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × mirdametinib × 1 year × Clear all

NCT07521657 2026-04-13

NF118

University of Alabama at Birmingham

Phase 2 Not yet recruiting

Glioblastoma, Glioma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡